Elliott's Citgo Deal Gains Momentum After Maduro's Exit

Hedge fund Elliott Investment Management is poised to finalise its controversial $6 billion takeover of Venezuela's US-based Citgo Petroleum. The political shift in Caracas could boost the refiner's value. Read the full analysis.

Market Dips, 5 Breakout Stocks to Buy on Jan 5

Indian markets closed lower on January 5 amid profit-booking. Get expert technical analysis on Nifty, Bank Nifty, and 5 breakout stock recommendations for short-term trades.

Indian Pharma's Innovation Success in 2025

Indian pharmaceutical companies, long known for generics, saw their risky innovation bets yield major commercial success in 2025 through global deals and approvals. Discover the key players and what's next for 2026.

ICICI Prudential CIO: Avoid Gold, Silver as Solo Bets

ICICI Prudential Mutual Fund's Sankaran Naren advises caution on precious metals, recommends equity-focused asset allocation. He cites high valuations and equity supply for moderate market returns.

Karnal Pharma Park Delays Leave Drug Makers in Limbo

Pharmaceutical manufacturers in Haryana await land allocation for the Karnal Pharma Park, a project delayed since 2021. The park promises to boost drug production and exports. Read about the industry's demands and government's plans.

Page 11 of 479